181 related articles for article (PubMed ID: 30515965)
1. An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer.
Geng B; Liang M; Qin L; Zhao W; Wang H; Wang L; Pan X; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1458-1469. PubMed ID: 30515965
[TBL] [Abstract][Full Text] [Related]
2. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.
Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y
J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525
[No Abstract] [Full Text] [Related]
3. miR-4698-Trim59 axis plays a suppressive role in hepatocellular carcinoma.
Yu D; Zhu L; Tu H; Wu L; Yang H; Xu C
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1120-1131. PubMed ID: 32114426
[TBL] [Abstract][Full Text] [Related]
4. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
5. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
6. TRIM59, amplified in ovarian cancer, promotes tumorigenesis through the MKP3/ERK pathway.
Tong X; Mu P; Zhang Y; Zhao J; Wang X
J Cell Physiol; 2020 Nov; 235(11):8236-8245. PubMed ID: 31951023
[TBL] [Abstract][Full Text] [Related]
7. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
8. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.
Tian Y; Guo Y; Zhu P; Zhang D; Liu S; Tang M; Wang Y; Jin Z; Li D; Yan D; Li G; Zhu X
Aging (Albany NY); 2019 Oct; 11(19):8623-8641. PubMed ID: 31600735
[TBL] [Abstract][Full Text] [Related]
10. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
[TBL] [Abstract][Full Text] [Related]
11.
Pan H; Hong Y; Yu B; Li L; Zhang X
Cancer Biother Radiopharm; 2019 Jun; 34(5):334-341. PubMed ID: 30844301
[No Abstract] [Full Text] [Related]
12. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
13. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
14. TRIM59 promotes osteosarcoma progression via activation of STAT3.
Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
[TBL] [Abstract][Full Text] [Related]
15. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis.
Wang F; Wang H; Sun L; Niu C; Xu J
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C392-C401. PubMed ID: 32348176
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
20. The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.
Zhang JN; Ding DY; Yang SY; Tao QF; Yang Y; Zhou WP
Pathol Res Pract; 2022 Aug; 236():153989. PubMed ID: 35753134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
